| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.097 | 0.06 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.06 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |